Skip to Main Content

Paper Details

Dimethyl fumarate downregulates the immune response through the HCA<sub>2</sub>/GPR109A pathway: Implications for the treatment of multiple sclerosis.
Mult Scler Relat Disord
19
2018
Author NameAffiliation
Clare Baecher-AllanAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2